Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis

NCT00743262 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Atos Medical AB

Collaborators